Treasury increases pharmaceutical spending by 28.8 million for September prescriptions

The Department of Economy, Finance and Public Administration of the Generalitat has authorized a credit extension of 28,840,611.88 euros in the pharmacy prescription drug expenditure line, after it was found that the available credit was insufficient to pay the invoices for September 2026. The decision is published in the Official Gazette of the Generalitat Valenciana (DOGV) no. 10491, of November 11, 2026, within section III of administrative acts, via the Resolution of October 16, 2026 (reference DOGV-C-2026-33103, file 00.022/26).

Law 4/2026, of July 22, on the Generalitat budgets for the 2026 financial year includes in the budgetary subprogram 412B23 Pharmaceutical Benefits, in chapter IV, the transfer line T0006 “Pharmacy prescription drug expenditure”, where expenses derived from pharmacy and prescriptions issued in outpatient settings to non-hospitalized patients are allocated.

The extension is supported by article 48 of Law 1/2015, of February 6, on public finance, the instrumental public sector and subsidies, and by article 25.1.j) of the budget law, which grants the status of “extendable” to credits destined for the payment of pharmaceutical products from medical prescriptions.

Details of the extended credit

The resolution distributes the amount between two budgetary applications of chapter IV, both linked to line T0006:

• G01100202GEA0000.412B23.489.09: 10,096,867.12 euros.
• G01100202GEC0000.412B23.489.09: 18,743,744.76 euros.
• Total: 28,840,611.88 euros.

As a result of this operation, the transfers and subsidies annex of subprogram 412B23 increases the allocation of line T0006 with the following result:

• Previous allocation: 1,439,868,359.46 euros.
• Modification: 28,840,611.88 euros.
• Current allocation: 1,468,708,971.34 euros.

The shortfall detected in September

The origin of the measure is the analysis of the line’s execution carried out by the Directorate General of Pharmacy. According to the official text, the increase in healthcare demands from the population has caused the available credit to be insufficient to cover the pharmaceutical prescription benefit invoices corresponding to the month of September 2026.

It was the Department of Health itself that raised the need for credit for that exact amount and proposed extending line T0006, in order to cover the cost of outpatient prescription pharmacy for that month. The processing is also supported by articles 24 and 25 of the budget law.

Competence to resolve

The resolution is signed by the Undersecretary of Economy, Finance and Public Administration, Alida C. Mas Taberner, in Valencia, on October 16, 2026. The authority derives from the Resolution of February 12, 2024, regarding the delegation of certain powers to bodies of the department, published in DOGV no. 9792, of February 20.

The text consists of two operative sections: the first authorizes the credit expansion in the expenditure budget for the total amount indicated; the second transfers that increase to the annex of transfers and grants of the pharmaceutical benefits subprogram.

The operation directly affects the budgetary balance of Valencian healthcare: the monthly pharmaceutical bill already exceeds the annual forecast set in the 2026 budgets and necessitates increasing the allocation by nearly 29 million just to close September, one month before the bills for October, November, and December arrive. For pharmacy offices and patients, the agreement guarantees the continuity of payment for prescriptions dispensed in an outpatient setting.

Source: DOGV, no. 10491, November 11, 2026, section III (administrative acts), Resolution of October 16, 2026, of the Department of Economy, Finance and Public Administration (official reference: DOGV-C-2026-33103).